Trypanosoma cruzi: Altered parasites after in vitro treatment with gangliosides, a therapeutic agent in experimental Chagas' disease

Experimental Parasitology

Volumn 122, Issue 3, 2009, Pages 218-225

  Cossy Isasi, S ^a   Rodriguez M ^a   Pereira, B M I ^a   Diaz lujan C ^a   Fretes, R E ^a   Hauen D I ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Chagas' disease treatment; Gangliosides; GDH (EC 1.4.1.2); Kinetoplastidae; MDH (EC 1.1.1.37); Trypanosoma cruzi; Ultrastructure

Indexed keywords

GANGLIOSIDE; MEMBRANE ENZYME; PHOSPHOLIPASE A2;

ANISOTROPY; ARTICLE; CELL CULTURE; CELL DEATH; CELL MEMBRANE; CELL ORGANELLE; CELL VACUOLE; CHAGAS DISEASE; CULTURE MEDIUM; ENERGY RESOURCE; EPIMASTIGOTE; HETEROCHROMATIN; IN VITRO STUDY; KINETOPLAST; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

TRYPANOSOMA CRUZI;

EID: 65949112952     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.03.017     Document Type: Article

References (51)

1. Aggarwal R., Sanyal S.N., and Khera S. Lipid metabolism and low molecular weight solute uptake in Ascaridia galli. Acta Veterinaria Hungarica 37 (1989) 335-347
2. Avila J.L., Rojas M., and Avila A. Increase in asialoganglioside- and monosialoganglioside-reactive antibodies in chronic Chagas' disease patients. American Journal of Tropical Medicine and Hygiene 58 (1998) 338-342
3. Bonet A.H., Cichero J.A., Kushnir R.E., Grand J.C., and Segura E.L. Estudio epidemiológico de la enfermedad de Chagas Mazza en comunidades rurales de la Provincia de Córdoba. La Semana Médica 133 (1968) 581-587
4. Braga M.V., Urbina J.A., and de Souza W. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. International Journal of Antimicrobial Agents 24 (2004) 72-78
5. Brenzan M.A., Nakamura C.V., Prado Dias F.B., Ueda-Nakamura T., Young M.C., and Aparicio Garcia C.D. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitology Research 101 (2007) 715-722
6. Bronia D.H., Pereira B.M., Lujan H.D., Fretes R.E., Fernandez A., and Paglini P.A. Ganglioside treatment of acute T. cruzi infection in mice promotes long-term survival and parasitological cure. Annals of Tropical Medicine and Parasitology 93 34 (1999) 1-50
7. Calderon R.O., Aguerri A.M., and Bronia D.H. Trypanosoma cruzi: variable fusogenic ability by different growth phases of the epimastigote form. Experimental Parasitology 62 (1986) 453-455
8. Calderon R.O., Lujan H.D., Aguerri A.M., and Bronia D.H. Trypanosoma cruzi: involvement of proteolytic activity during cell fusion induced by epimastigote form. Molecular and Cellular Biochemistry 86 (1989) 189-200
9. Carlomagno M., Cura E., Perez A., and y Segura E. Informe sobre chagas. Ciencia Hoy 1 (1989) 36-44
10. Carneiro V.T.C., and Caldas R.A. Regulatory studies of l-glutamate dehydrogenase from Trypanosoma cruzi epimastigotes. Comparative Biochemistry and Physiology B 75 (1983) 61-64
11. Castro J.A., de Mecca M.M., and Bartel L.C. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Human and Experimental Toxicology 25 (2006) 471-479
12. Cazzulo J.J. Aerobic fermentation of glucose by trypanosomatids. The FASEB Journal 6 (1992) 3153-3161
13. Cazzulo J.J. Intermediate metabolism in Trypanosoma cruzi. Journal of Bioenergetics and Biomembranes 26 (1994) 157-165
14. Chen S.Y., Yang B., Jacobson K., and Sulik K.K. The membrane disordering effect of ethanol on neural crest cells in vitro and the protective role of GM1 ganglioside. Alcohol 13 (1996) 589-595
15. Confalonieri A.N., Martin N.F., Zingales B., Colli W., and de Lederkremer R.M. Sialoglycolipids in Trypanosoma cruzi. Biochemistry International 7 (1985) 215-222
16. Cossy Isasi S., Fernandez A.R., Paglini P., and Bronia D.H. GM1 ganglioside induced myocardial restoration and survival of mice with experimental Chagas' disease. Acta Tropica 73 (1999) 295-302
17. de Lederkremer R.M., Zingales B., Confalonieri A.N., Couto A.S., Martin N.F., and Colli W. In vivo incorporation of palmitic acid and galactose in glycolipids of Trypanosoma cruzi epimastigotes. Biochemistry International 10 (1985) 79-88
18. Duschak V.G., and Cazzulo J.J. Subcellular localization of glutamate dehydrogenases and alanine aminotransferase in epimastigotes of Trypanosoma cruzi. FEMS Microbiology Letters 67 (1991) 131-135
19. Elliot-Smith E., Speak A.O., Lloyd-Evans E., Smith D.A., Spoel A.C., Jeyakumar M., Butters T.D., Dwek R.A., d'Azzo A., and Platt F.M. Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. Molecular Genetics and Metabolism 94 (2008) 204-211
20. Ferrero-Garcia M.A., Trombetta S.E., Sanchez D.O., Reglero A., Frasch A.C., and Parodi A.J. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins. European Journal of Biochemistry 213 (1993) 765-771
21. Fighera M.R., Sartori Bonini J., Grendene de Oliveira T., Frussa-Filho R., Teixeira Rocha J.B., Dutra-Filho C.S., Antonello Rubin M., and Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. The International Journal of Biochemistry and Cell Biology 35 (2003) 465-473
22. Fretes R.E., and de Fabro S.P. In vivo and in vitro analysis of lysosomes and acid phosphatase activity in human chagasic placentas. Experimental and Molecular Pathology 63 (1995) 153-160
23. Galisteo M., Rissel M., Sergent O., Chevanne M., Cillard J., Guillouzo A., and Lagadic-Gossmann D. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation. The Journal of Pharmacology and Experimental Therapeutics 294 (2000) 160-167
24. Garrido M.N., Racagni G., Pereira B.M., Rodríguez M.A., Luján H.D., Bronia D.H., and Machado-Domenech E.E. Changes in Trypanosoma cruzi phospholipid turnover induced by parasite contact with cell membranes. Parasitology Research 86 (2000) 96-100
25. Ghidoni R., Houri J.J., Giuliani A., Ogier-Denis E., Parolari E., Botti S., Bauvy C., and Codogno P. The metabolism of sphingo(glyco)lipids is correlated with the differentiation-dependent autophagic pathway in HT-29 cells. European Journal of Biochemistry 237 (1996) 454-459
26. Hunter G.R., Hellman U., Cazzulo J.J., and Nowicki C. Tetrameric and dimeric malate dehydrogenase isoenzymes in Trypanosoma cruzi epimastigotes. Molecular and Biochemical Parasitology 105 (2000) 203-214
27. Inagaki M., Matsunaga Y., Konagaya N., Nishikawa S., and Kashimura N. Effects of ganglioside GD1a on the fluidity and phase transition of phosphatidylcholine model membrane immobilized on porous cellulose acetate filter. Bioscience, Biotechnology, and Biochemistry 60 (1996) 1976-1981
28. Karnovsky M.J. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. The Journal of Cell Biology 27 (1965) 137A
29. Lakowicz J.R. Fluorescence anisotropy. In: Lakowicz J.R. (Ed). Principles of Fluorescence Spectroscopy (2006), Springer US, Singapore 353-382 (Chapter 10)
30. Luize P.S., Ueda-Nakamura T., as Filho B.P., Cortez D.A., Morgado-Diaz J.A., de Souza W., and Nakamura C.V. Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi. Parasitology Research 100 (2006) 31-37
31. Lujan H.D., and Bronia D.H. Intermembrane lipid transfer during Trypanosoma cruzi-induced erythrocyte membrane destabilization. Parasitology 108 (1994) 323-334
32. Lujan H.D., Paglini P., Fretes R., Fernandez A., Fidelio G.D., and Bronia D.H. Effect of gangliosides on Trypanosoma cruzi infection in mice. Life Science 53 (1993) L69-L73
33. Martinet W., De Bie M., Schrijvers D.M., De Meyer G.R., Herman A.G., and Kockx M.M. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (2004) 2296-2301
34. Maya J.D., Cassels B.K., Iturriaga-Vasquez P., Ferreira J., Faundez M., Galanti N., Ferreira A., and Morello A. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology 146 (2007) 601-620
35. Moll C., Peris P., Moreno A., Munoz J., and Guanabens N. Severe invalidating pain syndrome associated with benznidazole therapy for Chagas' disease. Clinical Rheumatology 27 (2007) 269-270
36. Moss J., Fishman P.H., Richards R.L., Alving C.R., Vaughan M., and Brady R.O. Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1. Proceedings of the National Academy of Sciences of the United States of America 73 (1976) 3480-3483
37. Murta S.M., and Romanha A.J. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116 (1998) 165-171
38. Murta S.M., Gazzinelli R.T., Brener Z., and Romanha A.J. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Molecular and Biochemical Parasitology 93 (1998) 203-214
39. Nishio M., Fukumoto S., Furukawa K., Ichimura A., Miyazaki H., Kusunoki S., Urano T., and Furukawa K. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. Journal of Biological Chemistry 279 (2004) 33368-33378
40. Persat F., Bouhours J.F., Petavy A.F., and Mojon M. Gangliosides of Echinococcus multilocularis metacestodes. Biochimica et Biophysica Acta 1225 (1994) 297-303
41. Sarti P., Antonini G., Malatesta F., Vallone B., Brunori M., Masserini M., Palestini P., and Tettamanti G. Effect of gangliosides on membrane permeability studied by enzymic and fluorescence-spectroscopy techniques. Biochemical Journal 267 (1990) 413-416
42. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 (1985) 76-85
43. Sorice M., Griggi T., Nicodemo G., Garofalo T., Marangi M., Sanguigni S., Becker S.I., and Mirelman D. Evidence for the existence of ganglioside molecules in the antigen of Entamoeba histolytica. Parasite Immunology 18 (1996) 133-137
44. Sosa Estani S. Prevalence and morbidity of chagasic infection in a rural population of Santiago del Estero province, República Argentina. Revista da Sociedade Brasileira de Medicina Tropical 27 (1994) 109-110
45. Takamura A., Higaki K., Kajimaki K., Otsuka S., Ninomiya N., Matsuda J., Ohno K., Suzuki Y., and Nanba E. Enhanced autophagy and mitochondrial aberrations in murine GM1-gangliosidosis. Biochemical and Biophysical Research Communications 367 (2008) 616-622
46. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., and Wittner M. Chagas' disease. Clinical Microbiology Reviews 5 (1992) 400-419
47. Urbina J.A. Intermediary metabolism of Trypanosoma cruzi. Parasitology Today 10 (1994) 107-110
48. Van den Bosch H. Intracellular Phospholipases A. Biochimica et Biophysica Acta 604 (1980) 191-246
49. Villarreal D., Nirde P., Hide M., Barnabe C., and Tibayrenc M. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites. Antimicrobial Agents and Chemotherapy 49 (2005) 2701-2709
50. von Euler G., Fuxe K., and Bondy S.C. Ganglioside GM1 prevents and reverses toluene-induced increases in membrane fluidity and calcium levels in rat brain synaptosomes. Brain Research 508 (1990) 210-214
51. Zingales B., Carniol C., de Lederkremer R.M., and Colli W. Direct sialic acid transfer from a protein donor to glycolipids of trypomastigote forms of Trypanosoma cruzi. Molecular and Biochemical Parasitology 26 (1987) 135-144